Emeritus Research Icon Circle Icon Left Arrow Right Arrow Up Arrow Facebook Icon Instagram Icon LinkedIn Icon Process Circle Right Process Circle Left Process Circle Process Circle Bottom

Therapeutic Area

Ankylosing Spondylitis
(Reference No: M098)

Eligibility Criteria

Males and Females aged 18+ years, who have been diagnosed with ankylosing spondylitis and have had inadequate treatment responses to 2 or more nonsteroidal anti-inflammatory drugs (NSAIDs) and who have not previously taken biologic disease-modifying antirheumatic drugs (bDMARDs).

Trial Details

Approx. 19 clinic visits over  2 years.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

 

Status

Currently recruiting Register

Therapeutic Area

Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Ulcerative Colitis or Hidradenitis Suppurativa
(Reference No: P17)

Eligibility Criteria

Males and Females aged 18+ years, who have been diagnosed with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis or hidradenitis suppurativa and are currently taking Humira (adalimumab).

 

Trial Details

Approx. 10 telephone/email contacts over 12 months.

Status

Currently recruiting Register

Therapeutic Area

Osteoarthritis - Knee
(Reference No: SUB)

Eligibility Criteria

Males and Females aged 40 to 65 years and who have been diagnosed with osteoarthritis of the knee, have a BMI of <35 kg/m2 and are not currently taking fish or krill oil supplements.

Trial Details

Approx. 5 clinic visits + 4 online surveys over 6 months.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

Psoriatic Arthritis
(Reference No: RHCF)

Eligibility Criteria

Males and Females aged 18+ years and who have been diagnosed with psoriatic arthritis and have not previously taken biologic disease-modifying anti-rheumatic drugs (bDMARDs).

Trial Details

Approx. 11 clinic visits over 12 months.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

Rheumatoid Arthritis
(Reference No: MCB)

Eligibility Criteria

Males and Females aged 18+ years and who have been diagnosed with rheumatoid arthritis and have taken Enbrel (etanercept) for at least 6 months.

Trial Details

Approx. 5 clinic visits over 12 months.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

Rheumatoid Arthritis
(Reference No: RA2017)

Eligibility Criteria

Males and Females aged 18+ years and who have been diagnosed with rheumatoid arthritis and have taken Enbrel (etanercept) for at least 6 months.

Trial Details

Approx. 7 clinic visits over 12 months.

Travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

Atopic Dermatitis (Reference No: B1012)

Eligibility Criteria

Males and Females aged 12+ years, who have had a diagnosis of chronic atopic dermatitis (atopic eczema) for at least 12 months and meet one of the following criteria:

  • Inadequate treatment responses to topical medications for at least 4 weeks;
  • Topical treatments are medically inadvisable; or
  • Required systemic therapies for disease control.

Trial Details

Approx. 7 clinic visits  + 2 telephone contacts over 4 months.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

C. Difficile Vaccine
(Reference No: B509)

Eligibility Criteria

Males and Females aged 60+ years, who met one of the following criteria in the last 12 months:

  • 1 or more inpatient hospitalisations of 2 or more  nights;
  • 2 or more emergency department visits;
  • 10 outpatient visits to a hospital or clinic;
  • Resided in a nursing home; or
  • taken antibiotics (in the last 3 months only)

Trial Details

Approx. 5 clinic visits (inc. 3 vaccinations) + 2 telephone contacts over 12 months.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

Pneumococcal Vaccine
(Reference No: V114)

Eligibility Criteria

Males and Females aged 18 to 49 years, who meet one of the following criteria:

  • Type 1 or Type 2 Diabetes;
  • Chronic Liver Disease;
  • Chronic Obstructive Pulmonary Disease (COPD);
  • Chronic Heart Disease; or
  • Current smoker (defined as smoking every day or most days of the week)

Trial Details

Approx. 5 clinic visits (inc. 1 vaccination) + 2 telephone contacts over 12 months.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register

Therapeutic Area

Giant Cell Arteritis
(Reference No: C001)

Eligibility Criteria

Males and Females aged 50-85 years, who have been diagnosed with giant cell arteritis (GCA)

Trial Details

Approx. 12 clinic visits over 6 months.
There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Currently recruiting Register